Table 1. Characteristics of the whole participants.

		Discovery phase		Validation phase
		EEC	Control	EEC	Control
n		9	20	31	33
Age (years)		67.0 (55, 72)	50.9 (21, 69)	62.4 (48, 83)	59.6 (31, 82)
CA125 (U/ml)	<35	7	20	20	33
	>35	2	0	11	0
TNM stage	I–II	8	–	22	–
	III–IV	1	–	9	–
Differentiation	G1–G2	7	–	22	–
	G3	2	–	9	–
Pelvic effusion	+	1	0	8	0
	−	8	20	24	33
Body mass index (Kg/m2)	<27	3	7	10	13
	>27	6	13	21	20